Caricamento...
Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
Temozolomide is the current first-line treatment for glioblastoma patients but, because many patients are resistant to it, there is an urgent need to develop antitumor agents to treat temozolomide-resistant glioblastoma. Gossypol, a natural polyphenolic compound, has been studied as a monotherapy or...
Salvato in:
| Pubblicato in: | Biomolecules |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6843396/ https://ncbi.nlm.nih.gov/pubmed/31658771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9100595 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|